336 related articles for article (PubMed ID: 30838614)
1. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol.
Thanki K; Zeng X; Foged C
Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614
[TBL] [Abstract][Full Text] [Related]
2. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
3. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
Lokras A; Foged C; Thakur A
Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
[TBL] [Abstract][Full Text] [Related]
4. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery.
Wang L; Griffel B; Xu X
Methods Mol Biol; 2017; 1632():231-240. PubMed ID: 28730443
[TBL] [Abstract][Full Text] [Related]
7. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.
Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C
Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.
Lokras A; Thakur A; Wadhwa A; Thanki K; Franzyk H; Foged C
Front Bioeng Biotechnol; 2020; 8():601155. PubMed ID: 33520957
[TBL] [Abstract][Full Text] [Related]
9. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
10. Application of a Quality-By-Design Approach to Optimise Lipid-Polymer Hybrid Nanoparticles Loaded with a Splice-Correction Antisense Oligonucleotide: Maximising Loading and Intracellular Delivery.
Thanki K; Papai S; Lokras A; Rose F; Falkenberg E; Franzyk H; Foged C
Pharm Res; 2019 Jan; 36(3):37. PubMed ID: 30623253
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
Nagapoosanam AL; Ganesan N; Umapathy D; Moorthy RK; Arockiam AJV
Indian J Med Res; 2019 Mar; 149(3):345-353. PubMed ID: 31249199
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
14. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
15. Engineering of budesonide-loaded lipid-polymer hybrid nanoparticles using a quality-by-design approach.
Leng D; Thanki K; Fattal E; Foged C; Yang M
Int J Pharm; 2018 Sep; 548(2):740-746. PubMed ID: 28847667
[TBL] [Abstract][Full Text] [Related]
16. Elucidating the nanostructure of small interfering RNA-loaded lipidoid-polymer hybrid nanoparticles.
Aljabbari A; Lokras AG; Kirkensgaard JJK; Rades T; Franzyk H; Thakur A; Zhang Y; Foged C
J Colloid Interface Sci; 2023 Mar; 633():907-922. PubMed ID: 36508398
[TBL] [Abstract][Full Text] [Related]
17. Poly(lactide-
Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design.
de Groot AM; Thanki K; Gangloff M; Falkenberg E; Zeng X; van Bijnen DCJ; van Eden W; Franzyk H; Nielsen HM; Broere F; Gay NJ; Foged C; Sijts AJAM
Mol Ther Nucleic Acids; 2018 Jun; 11():159-169. PubMed ID: 29858051
[TBL] [Abstract][Full Text] [Related]
20. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]